Business Wire

HTEC Research Reveals the Real AI Scaling Challenge: It’s Not the Technology

3.2.2026 16:46:00 EET | Business Wire | Press release

Share

AI has moved from ambition to action. Every organization is deploying it. Yet for most enterprises, the real challenge is only just beginning.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260203951136/en/

HTEC, a global AI‑first provider of software and hardware design and engineering services, released Executive Summary: A Cross‑Industry View of the State of AI in 2025, a global research report capturing how senior executives are navigating the next phase of AI transformation—and why scaling value remains elusive.

Today, HTEC, a global AI‑first provider of software and hardware design and engineering services, released Executive Summary: A Cross‑Industry View of the State of AI in 2025, a global research report that captures how senior executives are navigating the next phase of AI transformation—and why scaling value remains elusive.

Based on insights from 1,529 C‑suite executives worldwide, the research offers one of the most comprehensive leadership perspectives to date on where AI is delivering impact, where it is stalling, and what separates experimentation from enterprise‑wide advantage.

AI Is Everywhere—But Rarely Fully Embedded

The data reveals a clear inflection point. AI adoption is now universal: 100% of organizations report active AI deployment. But scale remains the exception, not the rule.

Only 45% of executives say AI is fully embedded across multiple functions or products. The majority report fragmented deployments—AI running in pockets, pilots, or isolated initiatives rather than as a coordinated operating model.

For HTEC, this mirrors what clients experience on the ground. The challenge is no longer proving AI works. It is turning promising use cases into integrated systems and workflows that deliver measurable, repeatable ROI.

Where AI Momentum Breaks Down

Executives are remarkably aligned on why progress slows.

The first fracture point isn’t model performance—it’s integration.
The most frequently cited barrier is the difficulty of embedding AI into existing processes and legacy systems (43%). This is where initiatives stall, ownership fragments, and value erodes.

Internal capability gaps make “build everything in‑house” unrealistic.
As AI moves deeper into core operations, leaders acknowledge that shortages in critical technical skills create execution bottlenecks that compound over time.

Unclear prioritization and ROI force a shift in execution strategy.
With limited internal capacity and AI literacy to evaluate and scale multiple initiatives in parallel, executives increasingly plan to rely on specialized partners and third‑party platforms to accelerate deployment, reduce risk, and focus internal teams where they create the most value.

The message is consistent across industries: AI success is now constrained by organizational readiness, not algorithmic potential.

Edge AI Moves From Experimental to Essential

The research also highlights a decisive shift in how leaders view edge and embedded AI.

Edge AI is no longer seen as optional or experimental. Ninety‑two percent of executives report strong familiarity with edge capabilities and express confidence in deploying AI closer to where data is generated, and decisions are made—particularly to improve security, resilience, regulatory control, and performance in constrained environments.

At the same time, leaders are pragmatic about what it takes to scale. Most plan a blended approach: combining specialized partners, third‑party platforms, and selective in‑house development. The goal is speed without sacrificing control—and long‑term ownership without slowing execution.

The Cost of Inaction Is Measured in Years

Executives are acutely aware of the stakes. They estimate that failing to act on AI and edge opportunities could set their organizations back by nearly two years.

In response, most leaders are targeting one‑ to three‑year horizons to validate use cases, deploy enterprise roadmaps, upskill their workforce, and launch new AI‑enabled revenue streams.

Yet confidence remains fragile. Only 25% of executives believe their organization can adopt and scale AI rapidly. Another 22% expect selective adoption with slower scaling. Thirty‑one percent say they can experiment but struggle to capture value, while 22% admit they are already falling behind.

Taken together, the findings suggest a sobering reality: three in four organizations risk turning AI momentum into missed advantage unless they address structural, operational, and leadership barriers.

From Projects to Operating Model

“The next phase of AI is not about more pilots,” said Lawrence Whittle, Chief Strategy Officer at HTEC. “It’s about defining bold ambitions, redesigning end‑to‑end processes, and scaling AI through modular, enterprise‑wide roadmaps. Organizations that succeed will be those that treat AI as a core operating model—not a collection of projects.”

To explore the full findings and executive insights from the report, download Executive Summary: A Cross-Industry View of the State of AI in 2025.

About the Report

The report was commissioned by HTEC and conducted by Censuswide. It includes the insights from 1,529 C-suite leaders across the USA, UK, Germany, Spain, Saudi Arabia, and the UAE, spanning CEOs, CIOs, CTOs, CDOs, CFOs, COOs, CPOs, and CSOs across industries, including financial services, healthcare, automotive, telecommunications, retail, and semiconductors.

About HTEC

HTEC Group Inc. is a global AI-first provider of strategic, software and hardware embedded design and engineering services, specializing in Advanced Technologies, Financial Services, MedTech, Automotive, Telco, and Enterprise Software & Platforms. HTEC has a proven track record of helping Fortune 500 and hyper-growth companies solve complex engineering challenges, drive efficiency, reduce risks, and accelerate time to market. HTEC prides itself on attracting top talent and has strategically chosen the locations of its 20+ excellence centers to enable this.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260203951136/en/

Contacts

Media Contact:
media@htecgroup.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 17:00:00 EEST | Press release

PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpinned by global capacity, technical expertise, deep scientific knowledge, and an industry-leading quality and regulatory track record. This press release features multimedia. View the full release here: https://www.

Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 16:53:00 EEST | Press release

Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor

Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 16:00:00 EEST | Press release

Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world. “Data is only valuable when it’s activated,” said Steve Lucas, Chairman and CEO, Boomi. “At Boomi World 2026, we

Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 16:00:00 EEST | Press release

Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level in our clients’ complex matters,” said Jeny Maier, managing partner

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 16:00:00 EEST | Press release

Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug conjugates (ADCs). Central to Araris’ approach is its proprietary AraLinQ™ ADC technology, which enables the creation of stable and site-specific ADCs using standard antibodies with scalable manufacturing

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye